Ardsley Advisory Partners LP Axonics, Inc. Transaction History

Ardsley Advisory Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $6.22 Million - $8.26 Million	-105,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $1.03 Million - $1.34 Million	-20,000 Reduced 16.0%	105,000 $6.66 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $1.23 Million - $1.5 Million	-25,000 Reduced 16.67%	125,000 $7.49 Million
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $210,950 - $257,500	-5,000 Reduced 3.23%	150,000 $7.5 Million
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $529,950 - $765,600	15,000 Added 10.71%	155,000 $7.91 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $572,750 - $995,750	-25,000 Reduced 15.15%	140,000 $4.92 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $254,820 - $584,815	-15,500 Reduced 8.59%	165,000 $4.19 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $3.53 Million - $5.23 Million	180,500 New	180,500 $5 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.